G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/19/2002	CA2316402C Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
11/19/2002	CA2296698C Method and device for fixing micro- and/or nano-objects
11/19/2002	CA2277225C Method and apparatus for selectively injecting poultry eggs
11/19/2002	CA2222554C Method and apparatus for continuously monitoring and forecasting slide and specimen preparation for a biological specimen population
11/19/2002	CA2215164C In-situ oil analyzer and methods using same, particularly for continuous on-board analysis of diesel engine lubrication systems
11/19/2002	CA2143185C Method of detecting a change in the property of a rubber member
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2085374C Continuous rbcod measurement
11/19/2002	CA2063580C Receptor assay for fk-506
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/18/2002	CA2385735A1 A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
11/16/2002	CA2383556A1 High-efficiency assay for protein mannosyl transferases
11/15/2002	CA2385816A1 Gas sensor and method for measuring gas concentration using the same
11/14/2002	WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	WO2002091425A2 Fast variable gain detector system and method of controlling the same
11/14/2002	WO2002091394A1 Differential photochemical & photomechanical processing
11/14/2002	WO2002091326A1 Mobile flue gas generator and method for testing a flue gas indicator
11/14/2002	WO2002091286A2 Analysis and presentation of internal features of logs
11/14/2002	WO2002090995A2 Assay system
11/14/2002	WO2002090994A2 Individualization of therapy with analgesics
11/14/2002	WO2002090993A2 Functional protein expression for rapid cell-free phenotyping
11/14/2002	WO2002090992A2 Screening method
11/14/2002	WO2002090991A2 Proteins and genes for diagnosis and treatment of erbb2-related cancer
11/14/2002	WO2002090990A1 Biopolymer-containing gel
11/14/2002	WO2002090989A2 Method for detecting blood cell antigens and the antibodies in response to the same
11/14/2002	WO2002090988A1 Object comprising an uncharged, functionalized hydrogel surface
11/14/2002	WO2002090987A2 Universal fluorescent sensors
11/14/2002	WO2002090986A1 Colon cancer antigen panel
11/14/2002	WO2002090985A1 Peptide-immobilized baseboard and method of assaying target protein using the same
11/14/2002	WO2002090983A2 Quantitative single-step immunoassay in lyophilised form
11/14/2002	WO2002090982A1 Methods for the identification of antiviral compounds
11/14/2002	WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002	WO2002090980A1 Eyestrain model, method of constructing the same, evaluation method with the use of the model and drugs screened by using the evaluatin method
11/14/2002	WO2002090979A1 Biochips and method of screening using drug induced gene and protein expression profiling
11/14/2002	WO2002090978A1 Method and apparatus for high-speed approximate sub-string searches
11/14/2002	WO2002090977A1 Method and system to test a substance for inflammatory or oxidant properties
11/14/2002	WO2002090976A2 Disposable cup and cone used in blood analysis instrumentation
11/14/2002	WO2002090975A2 Method and device for identifying volatile substances in solution
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090970A1 Proteome analysis method
11/14/2002	WO2002090969A1 Method of identifying phosphoprotein
11/14/2002	WO2002090967A1 Method for operating a sensor element
11/14/2002	WO2002090964A1 Method and apparatus to determine the performance of protein arrays
11/14/2002	WO2002090961A2 Systems and methods for detection of analytes in biological fluids
11/14/2002	WO2002090960A2 A method of measuring the concentration of hydrogen and methane in nitrogen by means of ion mobility spectrometry
11/14/2002	WO2002090959A2 A method for measuring the total concentration of carbon monoxide and hydrocarbons in oxygen by means of ion mobility spectrometry
11/14/2002	WO2002090958A2 Sessor and sensing method for detection and process control
11/14/2002	WO2002090945A2 Method of performing an assay, apparatus therefor, and a method of manufacturing and apparatus
11/14/2002	WO2002090941A2 Viscosity sensor
11/14/2002	WO2002090939A1 Equipment for determining weight per unit area
11/14/2002	WO2002090937A2 Method and device for removing waste water samples
11/14/2002	WO2002090934A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
11/14/2002	WO2002090932A2 Methods and reagents for identifying insulin response modulators and therapeutic uses therefor
11/14/2002	WO2002090931A2 Methods for determining the prognosis for cancer patients using tucan
11/14/2002	WO2002090930A2 Stabilizing peroxides with stannous halides
11/14/2002	WO2002090929A2 Process for analyzing protein samples
11/14/2002	WO2002090927A2 Matrix assays in genomically indexed cells
11/14/2002	WO2002090926A2 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002	WO2002090924A2 Mutation induced optimization of receptor signal to noise ratio
11/14/2002	WO2002090923A2 Methods for assembling protein microarrays
11/14/2002	WO2002090920A2 Method and device for determining a characteristic value that is representative of the condition of a gas
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090595A1 Methods for modulating an immune response by modulating krc activity
11/14/2002	WO2002090593A1 Screening for enzyme inhibitors
11/14/2002	WO2002090592A1 Method for evaluating and applying an individual's genetic characteristics to determine response to cardiovascular medication therapy
11/14/2002	WO2002090587A1 Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same
11/14/2002	WO2002090583A2 Skin treatment
11/14/2002	WO2002090579A1 Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression
11/14/2002	WO2002090578A2 Methods and means of histone methylation
11/14/2002	WO2002090577A2 Positive response biosensors and other sensors
11/14/2002	WO2002090576A1 Methods and compositions for the treatment and diagnosis of body weight disorders
11/14/2002	WO2002090574A1 Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
11/14/2002	WO2002090573A2 Biochip arrangement
11/14/2002	WO2002090569A2 Family-based association tests for quantitative traits using pooled dna
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090565A2 Magnetic beads and uses thereof
11/14/2002	WO2002090562A2 Methods for the reduction of stutter in microsatellite amplification
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090544A2 Protein-protein interactions in adipocyte cells (3)
11/14/2002	WO2002090542A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
11/14/2002	WO2002090541A1 Determination of a genetic predisposition for behavioural disorders
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090528A1 Soft tissue devices and methods of use
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090518A2 Differential regulation of t cell survival and proliferation
11/14/2002	WO2002090511A2 Method for the isolation of stem cells by immuno-labeling with hla/mhc gene product marker
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090498A2 A high throughput assay for identification of gene expression modifiers
11/14/2002	WO2002090443A1 Synthesis and evaluation of new cyanine dyes as minor groove of [poly(da-dt)]2 binders
11/14/2002	WO2002090389A1 Monoclonal antibody for nkx3.1 and method for detecting same
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002090319A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
11/14/2002	WO2002089985A2 Container for an analysis chip
11/14/2002	WO2002089984A1 High throughput microarray spotting system and method
11/14/2002	WO2002089973A2 Affinity reaction probe detection/analysis chips and detection system and apparatus using the same
11/14/2002	WO2002089972A1 Microfluidic device for analyzing nucleic acids and/or proteins, methods of preparation and uses thereof
11/14/2002	WO2002089943A1 Method for screening microcrystallizations for crystal formation

1 ... 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 ... 3937